Filing Details

Accession Number:
0001415889-25-009482
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-01 21:45:05
Reporting Period:
2025-03-28
Filing Date:
2025-04-01
Accepted Time:
2025-04-01 21:45:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711968 Leonard Steven Chapman C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-28 18,750 $0.00 222,104 No 4 M Direct
Common Stock Disposition 2025-03-31 9,311 $138.41 212,793 No 4 S Direct
Common Stock Disposition 2025-03-31 252 $138.42 212,541 No 4 S Direct
Common Stock Disposition 2025-04-01 2,515 $139.39 210,026 No 4 S Direct
Common Stock Disposition 2025-04-01 8,027 $140.20 201,999 No 4 S Direct
Common Stock Disposition 2025-04-01 4,022 $141.11 197,977 No 4 S Direct
Common Stock Disposition 2025-04-01 1,334 $142.28 196,643 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2025-03-28 18,750 $0.00 18,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,750 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 22, 2021.
  3. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.67 to $139.63 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.68 to $140.67 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.71 to $141.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.12 to $142.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. On January 22, 2021, the Reporting Person was granted RSUs covering 75,000 shares of Common Stock which vest in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. On March 28, 2025, the criteria was satisfied for the vesting of RSUs covering 18,750 shares of Common Stock.